Patent · US Active

Using tumor-navigating Salmonella to modulate tumor metabolism

US11717542B2 · kind B2 · utility

0Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 20, 2020
Grant dateAug 8, 2023
Priority date
Expiry dateFeb 20, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to genetically modified strains of Salmonella, engineered to be tumor navigating and to alter tumor metabolism in the tumor microenvironment. Also provided herein are methods of producing and methods of using such genetically modified Salmonella strains to treat cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.